Lefebvre founded Travelers’ internal professional ... Anil Bhatt serves as Elevance Health’s Global Chief Information Officer. He is a passionate technology leader who is always thinking ...

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results exceeds consensus. Read more here.

Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.

Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to Neutral. Analyst Price Forecast Suggests 14.83% Upside As of April 1, 2025, the ...

Morgan Stanley raised the firm’s price target on Elevance Health (ELV) to $428 from $405 and keeps an Equal Weight rating on the shares. While ...

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best medical stocks to buy according to billionaires. Some experts view medical ...

Elevance Health, Inc. ELV is scheduled to release first-quarter 2025 results on April 22, before the opening bell. The Zacks ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...